Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julio Delgado

Showing results (61-70 of 232) with videos related to

Pageof 24
Sort By:
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|July 15, 2023
[Translated article] Advances in the work of multidisciplinary teams for the care of patients with severe uncontrolled asthma. A post-COVID vision (TEAM 2.0 project)Mónica Climente-Martí, Manuela Alvarado-Arenas, Pilar Ausín-Herrero, et al.
Journal of Asthma and Allergy|May 10, 2023
The ATLAS ASMA Study: Assessing the Impact of Asthma on Patients' Life - The Spanish Patients' PerspectiveJavier Dominguez-Ortega, Vicente Plaza, Antonio Nieto, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 16, 2013
Rituximab-based chemoimmunotherapy prolongs survival of patients with chronic lymphocytic leukemia independently of the time of administrationJulio Delgado, Gabriela Ghita, Tycho Baumann, et al.
Hemasphere|July 8, 2021
The European Medicines Agency Review of Crizanlizumab for the Prevention of Recurrent Vaso-Occlusive Crises in Patients With Sickle Cell DiseaseJulio Delgado, Caroline Voltz, Milena Stain, et al.
Cirugia Espanola|June 24, 2018
Evaluation of the treatment of head and neck cutaneous squamous cell carcinoma in the elderly: a survival analysisÁlvaro Jesús Bernal Martínez, Nieves Fernández Letamendi, Julio Delgado Martínez, et al.
Histopathology|March 25, 2009
Bcl-10 protein highly correlates with the expression of phosphorylated p65 NF-kappaB in peripheral T-cell lymphomas and is associated with clinical outcomeJavier Briones, Esther Moga, Iñigo Espinosa, et al.
Patient Preference and Adherence|February 25, 2021
Preference for Easyhaler<sup>®</sup> Over Previous Dry Powder Inhalers in Asthma Patients: Results of the DPI PREFER Observational StudyFrancisco Javier Alvarez-Gutiérrez, Ana Gómez-Bastero Fernández, Juan Francisco Medina Gallardo, et al.
Expert Review of Clinical Immunology|September 23, 2016
New developments in work-related asthmaSantiago Quirce, Paloma Campo, Javier Domínguez-Ortega, et al.
Leukemia Research|September 4, 2012
Retreatment with purine analogs in patients with chronic lymphocytic leukemiaIvan Dlouhy, Gabriela Ghita, Tycho Baumann, et al.
American Journal of Hematology|January 26, 2017
Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL-IPIJulio Delgado, Michael Doubek, Tycho Baumann, et al.
Pageof 24

Showing results (61-70 of 232) with videos related to

Sort By:
Pageof 24
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|July 15, 2023
[Translated article] Advances in the work of multidisciplinary teams for the care of patients with severe uncontrolled asthma. A post-COVID vision (TEAM 2.0 project)Mónica Climente-Martí, Manuela Alvarado-Arenas, Pilar Ausín-Herrero, et al.
Journal of Asthma and Allergy|May 10, 2023
The ATLAS ASMA Study: Assessing the Impact of Asthma on Patients' Life - The Spanish Patients' PerspectiveJavier Dominguez-Ortega, Vicente Plaza, Antonio Nieto, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 16, 2013
Rituximab-based chemoimmunotherapy prolongs survival of patients with chronic lymphocytic leukemia independently of the time of administrationJulio Delgado, Gabriela Ghita, Tycho Baumann, et al.
Hemasphere|July 8, 2021
The European Medicines Agency Review of Crizanlizumab for the Prevention of Recurrent Vaso-Occlusive Crises in Patients With Sickle Cell DiseaseJulio Delgado, Caroline Voltz, Milena Stain, et al.
Cirugia Espanola|June 24, 2018
Evaluation of the treatment of head and neck cutaneous squamous cell carcinoma in the elderly: a survival analysisÁlvaro Jesús Bernal Martínez, Nieves Fernández Letamendi, Julio Delgado Martínez, et al.
Histopathology|March 25, 2009
Bcl-10 protein highly correlates with the expression of phosphorylated p65 NF-kappaB in peripheral T-cell lymphomas and is associated with clinical outcomeJavier Briones, Esther Moga, Iñigo Espinosa, et al.
Patient Preference and Adherence|February 25, 2021
Preference for Easyhaler<sup>®</sup> Over Previous Dry Powder Inhalers in Asthma Patients: Results of the DPI PREFER Observational StudyFrancisco Javier Alvarez-Gutiérrez, Ana Gómez-Bastero Fernández, Juan Francisco Medina Gallardo, et al.
Expert Review of Clinical Immunology|September 23, 2016
New developments in work-related asthmaSantiago Quirce, Paloma Campo, Javier Domínguez-Ortega, et al.
Leukemia Research|September 4, 2012
Retreatment with purine analogs in patients with chronic lymphocytic leukemiaIvan Dlouhy, Gabriela Ghita, Tycho Baumann, et al.
American Journal of Hematology|January 26, 2017
Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL-IPIJulio Delgado, Michael Doubek, Tycho Baumann, et al.
Pageof 24